SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-039606
Filing Date
2013-05-09
Accepted
2013-05-09 16:16:55
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-8540_110q.htm 10-Q 781646
2 EX-31.1 a13-8540_1ex31d1.htm EX-31.1 12701
3 EX-31.2 a13-8540_1ex31d2.htm EX-31.2 12715
4 EX-32.1 a13-8540_1ex32d1.htm EX-32.1 4423
5 EX-32.2 a13-8540_1ex32d2.htm EX-32.2 4440
  Complete submission text file 0001104659-13-039606.txt   6354031

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20130331.xml EX-101.INS 683071
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20130331.xsd EX-101.SCH 96259
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20130331_cal.xml EX-101.CAL 55298
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20130331_def.xml EX-101.DEF 387491
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20130331_lab.xml EX-101.LAB 1213031
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20130331_pre.xml EX-101.PRE 557327
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 13829111
SIC: 2834 Pharmaceutical Preparations